IBDEI111 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16694,1,4,0)
 ;;=4^Z65.8
 ;;^UTILITY(U,$J,358.3,16694,2)
 ;;=^5063185
 ;;^UTILITY(U,$J,358.3,16695,0)
 ;;=Z86.11^^61^776^109
 ;;^UTILITY(U,$J,358.3,16695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16695,1,3,0)
 ;;=3^Personal Hx of Tuberculosis
 ;;^UTILITY(U,$J,358.3,16695,1,4,0)
 ;;=4^Z86.11
 ;;^UTILITY(U,$J,358.3,16695,2)
 ;;=^5063461
 ;;^UTILITY(U,$J,358.3,16696,0)
 ;;=Z86.13^^61^776^76
 ;;^UTILITY(U,$J,358.3,16696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16696,1,3,0)
 ;;=3^Personal Hx of Malaria
 ;;^UTILITY(U,$J,358.3,16696,1,4,0)
 ;;=4^Z86.13
 ;;^UTILITY(U,$J,358.3,16696,2)
 ;;=^5063463
 ;;^UTILITY(U,$J,358.3,16697,0)
 ;;=Z86.73^^61^776^106
 ;;^UTILITY(U,$J,358.3,16697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16697,1,3,0)
 ;;=3^Personal Hx of TIA & Cereb Infrc w/o Residual Deficits
 ;;^UTILITY(U,$J,358.3,16697,1,4,0)
 ;;=4^Z86.73
 ;;^UTILITY(U,$J,358.3,16697,2)
 ;;=^5063477
 ;;^UTILITY(U,$J,358.3,16698,0)
 ;;=Z86.79^^61^776^69
 ;;^UTILITY(U,$J,358.3,16698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16698,1,3,0)
 ;;=3^Personal Hx of Circulatory System Diseases
 ;;^UTILITY(U,$J,358.3,16698,1,4,0)
 ;;=4^Z86.79
 ;;^UTILITY(U,$J,358.3,16698,2)
 ;;=^5063479
 ;;^UTILITY(U,$J,358.3,16699,0)
 ;;=Z91.040^^61^776^57
 ;;^UTILITY(U,$J,358.3,16699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16699,1,3,0)
 ;;=3^Latex Allergy Status
 ;;^UTILITY(U,$J,358.3,16699,1,4,0)
 ;;=4^Z91.040
 ;;^UTILITY(U,$J,358.3,16699,2)
 ;;=^5063607
 ;;^UTILITY(U,$J,358.3,16700,0)
 ;;=Z92.3^^61^776^73
 ;;^UTILITY(U,$J,358.3,16700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16700,1,3,0)
 ;;=3^Personal Hx of Irradiation
 ;;^UTILITY(U,$J,358.3,16700,1,4,0)
 ;;=4^Z92.3
 ;;^UTILITY(U,$J,358.3,16700,2)
 ;;=^5063637
 ;;^UTILITY(U,$J,358.3,16701,0)
 ;;=Z91.120^^61^776^53
 ;;^UTILITY(U,$J,358.3,16701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16701,1,3,0)
 ;;=3^Intentional Underdose of Meds d/t Financial Hardship
 ;;^UTILITY(U,$J,358.3,16701,1,4,0)
 ;;=4^Z91.120
 ;;^UTILITY(U,$J,358.3,16701,2)
 ;;=^5063612
 ;;^UTILITY(U,$J,358.3,16702,0)
 ;;=Z91.11^^61^776^62
 ;;^UTILITY(U,$J,358.3,16702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16702,1,3,0)
 ;;=3^Noncompliance w/ Dietary Regimen
 ;;^UTILITY(U,$J,358.3,16702,1,4,0)
 ;;=4^Z91.11
 ;;^UTILITY(U,$J,358.3,16702,2)
 ;;=^5063611
 ;;^UTILITY(U,$J,358.3,16703,0)
 ;;=Z87.891^^61^776^97
 ;;^UTILITY(U,$J,358.3,16703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16703,1,3,0)
 ;;=3^Personal Hx of Nicotine Dependence
 ;;^UTILITY(U,$J,358.3,16703,1,4,0)
 ;;=4^Z87.891
 ;;^UTILITY(U,$J,358.3,16703,2)
 ;;=^5063518
 ;;^UTILITY(U,$J,358.3,16704,0)
 ;;=Z77.090^^61^776^3
 ;;^UTILITY(U,$J,358.3,16704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16704,1,3,0)
 ;;=3^Asbestos Contact/Exposure
 ;;^UTILITY(U,$J,358.3,16704,1,4,0)
 ;;=4^Z77.090
 ;;^UTILITY(U,$J,358.3,16704,2)
 ;;=^5063312
 ;;^UTILITY(U,$J,358.3,16705,0)
 ;;=Z57.8^^61^776^65
 ;;^UTILITY(U,$J,358.3,16705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16705,1,3,0)
 ;;=3^Occupational Exposure to Other Risk Factors
 ;;^UTILITY(U,$J,358.3,16705,1,4,0)
 ;;=4^Z57.8
 ;;^UTILITY(U,$J,358.3,16705,2)
 ;;=^5063127
 ;;^UTILITY(U,$J,358.3,16706,0)
 ;;=Z77.21^^61^776^46
 ;;^UTILITY(U,$J,358.3,16706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16706,1,3,0)
 ;;=3^Hazardous Body Fluid Contact/Exposure
 ;;^UTILITY(U,$J,358.3,16706,1,4,0)
 ;;=4^Z77.21
